Manchester Capital Management LLC raised its holdings in UnitedHealth Group Incorporated (NYSE:UNH) by 2.4% during the 2nd quarter, according to its most recent filing with the Securities and Exchange Commission. The fund owned 7,755 shares of the healthcare conglomerate’s stock after buying an additional 180 shares during the period. Manchester Capital Management LLC’s holdings in UnitedHealth Group were worth $1,438,000 at the end of the most recent reporting period.

Other hedge funds have also modified their holdings of the company. Marshall Wace LLP increased its stake in UnitedHealth Group by 441.4% in the 2nd quarter. Marshall Wace LLP now owns 13,935 shares of the healthcare conglomerate’s stock valued at $2,578,000 after buying an additional 11,361 shares during the last quarter. Schwab Charles Investment Management Inc. increased its stake in UnitedHealth Group by 5.3% in the 2nd quarter. Schwab Charles Investment Management Inc. now owns 3,656,975 shares of the healthcare conglomerate’s stock valued at $678,077,000 after buying an additional 183,401 shares during the last quarter. American Century Companies Inc. increased its stake in UnitedHealth Group by 16.9% in the 2nd quarter. American Century Companies Inc. now owns 4,703,113 shares of the healthcare conglomerate’s stock valued at $872,051,000 after buying an additional 681,111 shares during the last quarter. Essex Financial Services Inc. increased its stake in UnitedHealth Group by 12.3% in the 2nd quarter. Essex Financial Services Inc. now owns 8,846 shares of the healthcare conglomerate’s stock valued at $1,640,000 after buying an additional 967 shares during the last quarter. Finally, Factory Mutual Insurance Co. increased its stake in UnitedHealth Group by 20.9% in the 2nd quarter. Factory Mutual Insurance Co. now owns 416,600 shares of the healthcare conglomerate’s stock valued at $77,245,000 after buying an additional 72,000 shares during the last quarter. Hedge funds and other institutional investors own 86.17% of the company’s stock.

Shares of UnitedHealth Group Incorporated (NYSE UNH) opened at $211.07 on Friday. The company has a quick ratio of 0.72, a current ratio of 0.70 and a debt-to-equity ratio of 0.52. The stock has a market cap of $204,080.00, a PE ratio of 21.95, a price-to-earnings-growth ratio of 1.56 and a beta of 0.64. UnitedHealth Group Incorporated has a twelve month low of $146.01 and a twelve month high of $213.93.

UnitedHealth Group (NYSE:UNH) last posted its quarterly earnings data on Tuesday, October 17th. The healthcare conglomerate reported $2.66 earnings per share (EPS) for the quarter, beating the Zacks’ consensus estimate of $2.57 by $0.09. UnitedHealth Group had a net margin of 4.50% and a return on equity of 21.52%. The firm had revenue of $50.32 billion during the quarter, compared to the consensus estimate of $50.38 billion. During the same quarter in the previous year, the firm posted $2.17 EPS. The business’s revenue for the quarter was up 8.7% compared to the same quarter last year. equities research analysts expect that UnitedHealth Group Incorporated will post 9.99 earnings per share for the current fiscal year.

The company also recently declared a quarterly dividend, which will be paid on Tuesday, December 12th. Stockholders of record on Friday, December 1st will be issued a dividend of $0.75 per share. This represents a $3.00 dividend on an annualized basis and a dividend yield of 1.42%. The ex-dividend date is Thursday, November 30th. UnitedHealth Group’s dividend payout ratio (DPR) is presently 34.09%.

UNH has been the topic of several recent research reports. Bank of America Corporation lifted their price target on shares of UnitedHealth Group from $210.00 to $214.00 and gave the company a “buy” rating in a research note on Friday, July 14th. Cowen and Company restated a “buy” rating on shares of UnitedHealth Group in a research note on Friday, July 14th. Mizuho set a $235.00 price objective on shares of UnitedHealth Group and gave the stock a “buy” rating in a research note on Tuesday, July 18th. BidaskClub lowered shares of UnitedHealth Group from a “strong-buy” rating to a “buy” rating in a research note on Wednesday, July 19th. Finally, UBS AG restated a “positive” rating and set a $213.00 price objective (up from $194.00) on shares of UnitedHealth Group in a research note on Wednesday, July 19th. Three investment analysts have rated the stock with a hold rating and twenty-four have assigned a buy rating to the stock. The company presently has a consensus rating of “Buy” and a consensus price target of $216.65.

In other news, Director Gail R. Wilensky sold 5,600 shares of the company’s stock in a transaction that occurred on Tuesday, September 5th. The shares were sold at an average price of $199.49, for a total transaction of $1,117,144.00. Following the completion of the sale, the director now owns 60,834 shares of the company’s stock, valued at approximately $12,135,774.66. The sale was disclosed in a legal filing with the SEC, which is accessible through this hyperlink. Also, insider Larry C. Renfro sold 50,574 shares of the company’s stock in a transaction that occurred on Friday, September 15th. The stock was sold at an average price of $198.11, for a total transaction of $10,019,215.14. Following the sale, the insider now directly owns 195,625 shares of the company’s stock, valued at approximately $38,755,268.75. The disclosure for this sale can be found here. In the last ninety days, insiders have sold 72,149 shares of company stock valued at $14,212,342. 0.89% of the stock is currently owned by insiders.

ILLEGAL ACTIVITY NOTICE: This piece of content was originally posted by Watch List News and is the sole property of of Watch List News. If you are reading this piece of content on another site, it was illegally stolen and reposted in violation of US & international copyright & trademark legislation. The original version of this piece of content can be viewed at https://www.watchlistnews.com/manchester-capital-management-llc-acquires-180-shares-of-unitedhealth-group-incorporated-unh/1694865.html.

UnitedHealth Group Profile

UnitedHealth Group Incorporated is a health and well-being company. The Company operates through four segments: UnitedHealthcare, OptumHealth, OptumInsight and OptumRx. It conducts its operations through two business platforms: health benefits operating under UnitedHealthcare and health services operating under Optum.

Want to see what other hedge funds are holding UNH? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for UnitedHealth Group Incorporated (NYSE:UNH).

Institutional Ownership by Quarter for UnitedHealth Group (NYSE:UNH)

Receive News & Ratings for UnitedHealth Group Incorporated Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for UnitedHealth Group Incorporated and related companies with Analyst Ratings Network's FREE daily email newsletter.